AiTmedservices

16/03/2021

ProFound AI Version 3.0 for Digital Breast Tomosynthesis has received FDA clearance. The third generation ProFound AI algorithm offers up to a 10% improvement in specificity performance and offers up to 40% faster processing on the new PowerLook platform. To learn more about ProFound AI 3.0, visit https://bit.ly/2Q92UX2.

22/01/2021

18/12/2020

More than one-third of people living in the U.S. have missed routine cancer screenings due to COVID-19. According to the American Cancer Society, regular screening can help find certain cancers early, when they are most likely to be treated successfully. Learn more about the role of artificial intelligence in breast cancer screening and how it can improve detection from Dr. Axel Gräwingholt at https://bit.ly/37OQpVS.

24/11/2020

ProFound AI sales has exceed 1,000 installs since the products were launched, signaling the rapid and wide-spread adoption of the pioneering cancer detection software solution built on artificial intelligence. To learn more about the products and our recently expanded suite of breast health solutions, visit https://bit.ly/3nShE8m.

19/11/2020

Our expanded suite of breast care solutions includes the latest generation of ProFound AI for digital breast tomosynthesis ( ), ProFound AI for 2D mammography*, and ProFound AI Risk, now available in the US and EU. Pre-book a virtual meeting at at https://bit.ly/3kCLJH3 to learn more. *CE Mark countries only.